We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

48 hedge funds and large institutions have $7.84M invested in AEON Biopharma Inc in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 2

23% more funds holding

Funds holding: 39 → 48 (+9)

18% more capital invested

Capital invested by funds: $6.66M → $7.84M (+$1.18M)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
48
Holders Change
+9
Holders Change %
+23.08%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
1
Reduced
2
Closed
2
Calls
$1.07M
Puts
–
Net Calls
+$1.07M
Net Calls Change
-$19K

Top Buyers

Rank Fund Capital Flow
1
ECP
Empyrean Capital Partners
California
+$342K
2
SCM
Shaolin Capital Management
Florida
+$199K
3
Citadel Advisors
Citadel Advisors
Florida
+$120K
4
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$119K
5
CL
CSS LLC
Illinois
+$87.9K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$204K
2
WAM
Wolverine Asset Management
Illinois
-$4.39K
3
CAC
Cowen and Company
New York
-$3.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$2.81M – – –
LP
2
LMR Partners
United Kingdom
$1.95M – – –
AC
3
Athos Capital
Hong Kong
$290K – – –
ECP
4
Empyrean Capital Partners
California
$273K +$342K +466,666 New
DKCM
5
Davidson Kempner Capital Management
New York
$205K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$198K +$120K +163,217 +82%
CC
7
Covalis Capital
United Kingdom
$162K – – –
SCM
8
Segantii Capital Management
Hong Kong
$162K +$12.2K +16,666 New
SCM
9
Shaolin Capital Management
Florida
$159K +$199K +271,484 New
TCM
10
Tenor Capital Management
New York
$98K – – –
Blackstone Inc
11
Blackstone Inc
New York
$97K – – –
PC
12
Periscope Capital
Ontario, Canada
$97K – – –
UOC
13
UBS O'Connor
Illinois
$95K – – –
Parallax Volatility Advisers
14
Parallax Volatility Advisers
California
$95K +$119K +162,749 New
CH
15
CVI Holdings
Delaware
$92K – – –
FTCM
16
Fir Tree Capital Management
New York
$92K – – –
PAMP
17
Polar Asset Management Partners
Ontario, Canada
$88K – – –
CL
18
CSS LLC
Illinois
$70K +$87.9K +120,000 New
PMAM
19
Picton Mahoney Asset Management
Ontario, Canada
$68K – – –
Hudson Bay Capital Management
20
Hudson Bay Capital Management
Connecticut
$55K – – –
Verition Fund Management
21
Verition Fund Management
Connecticut
$55K – – –
Wells Fargo
22
Wells Fargo
California
$52K – – –
CCA
23
Castle Creek Arbitrage
Colorado
$49K – – –
ACA
24
Arena Capital Advisors
California
$49K +$60.9K +83,200 New
Goldman Sachs
25
Goldman Sachs
New York
$46K – – –
1
2

AEON.WS Hedge Fund Activity: Q3 2021 in Review

48 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q3 2021, worth a combined $7.84M — up 18% from $6.66M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AEON.WS positions and 2 closed out — a net gain of 9 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Empyrean Capital Partners, opening a new position worth an estimated $342K. The largest seller was Linden Advisors, exiting entirely with an estimated $204K sold.

  • 48 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q3 2021, up from 39 in Q2 2021.
  • Funds reported $7.84M of AEON Biopharma Inc stock for Q3 2021, up 18% quarter-over-quarter.
  • 11 funds opened new AEON Biopharma Inc positions in Q3 2021 and 2 closed out, a net change of +9 holders.
  • The largest AEON Biopharma Inc buyer in Q3 2021 was Empyrean Capital Partners, an estimated $342K added.
  • The largest AEON Biopharma Inc seller in Q3 2021 was Linden Advisors, an estimated $204K sold.

Based on aggregated 13F filings for Q3 2021.